PedAM
Pediatric Disease Annotations & Medicines
| Disease | renal cell carcinoma |
| Phenotype | C0153676|lung metastasis |
| Sentences | 6 |
| PubMedID- 20382632 | Successful outcomes using combination therapy of interleukin-2 and interferon-alpha for renal cell carcinoma patients with lung metastasis. |
| PubMedID- 20740155 | A computed tomography (ct) showed renal cell carcinoma with multiple lung metastasis and invasion to the inferior vena cava, resulting in a diagnosis of clinical stage t3bn0m1. |
| PubMedID- 21743281 | [successful interferon-alpha therapy of renal cell carcinoma with lung metastasis: a case report]. |
| PubMedID- 21642665 | Nephrectomized renal cell carcinoma patients with lung metastasis were treated with interleukin-2 (0.7 x 10(6) unit, 5 days a week) and interferon-alpha (6 x 10(6) iu, 3 days a week) for the first 8 weeks, and then with both interleukin-2 and interferon-alpha, 2 or 3 days a week for 16 additional weeks. |
| PubMedID- 26300773 | For example, a study that used combined juzen-taiho-to therapy with ifn-alpha on experimental lung metastasis of murine renal cell carcinoma, resulted in a dose-dependent inhibition of lung metastasis after five consecutive treatment doses in mice (muraishi et al., 2000). |
| PubMedID- 24434328 | Complete remission of lung metastasis in a patient with renal cell carcinoma has also been reported after adoptive transfer of γδ t cells67. |
Page: 1